Company Profile
Clearside Biomedical Stock Price, News & Analysis
- Ticker:
- CLSD
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for CLSD.
Company overview
Business overview
Clearside Biomedical is a drug-delivery and ophthalmology company focused on delivering therapies directly to the back of the eye. Its platform is built around improving how eye treatments reach retinal tissue.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Clearside sits in specialty ophthalmology biotechnology.
Business Model Characteristics
The company depends on delivery technology, clinical progress, and the ability to create an eye-care franchise.
Position Within the Biotechnology Landscape
Clearside is a niche ophthalmology catalyst name whose stock is tied to clinical and delivery milestones.
Future catalysts
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant. The market will care about whether the delivery method still differentiates the story.
Recent news
- 01
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
Source: Clearside Biomedical
- 02
- 03
Clearside Biomedical Announces Approval of XIPERE® Suprachoroidal Treatment for Uveitic Macular Edema in Canada
Source: Clearside Biomedical
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Clearside Biomedical do?
Clearside Biomedical is a drug-delivery and ophthalmology company focused on delivering therapies directly to the back of the eye. Its platform is built around improving how eye treatments reach retinal tissue.
On which exchange is CLSD stock listed?
Clearside Biomedical (CLSD) is associated with NASDAQ, United States, Biopharma.
What is Clearside?
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant.
Which conditions is Clearside Biomedical targeting with Clearside?
Clearside Biomedical is associated with ophthalmology based on its company overview and current catalyst commentary.
How does Clearside Biomedical describe recent progress with Clearside?
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant.
What is Biomedical?
Clearside Biomedical is a drug-delivery and ophthalmology company focused on delivering therapies directly to the back of the eye.
What should investors watch for with Biomedical?
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant. The market will care about whether the delivery method still differentiates the story.
What future catalysts are investors watching for Clearside Biomedical?
Clearside’s catalysts are suprachoroidal delivery programs and any ophthalmology update that keeps the platform relevant. The market will care about whether the delivery method still differentiates the story.